EGFL7 and colorectal carcinoma: Furthermore, we have previously shown a relationship between high expression levels of EGFL7 in CRC tissue and reduced response rate (RR) in the metastatic setting11, 12, and antibodies targeting EGFL7 have demonstrated efficacy in early phases of clinical testing17.